MedTrace Logo

Computerized Registry of Patients With Venous Thromboembolism (RIETE)

NCT02832245 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 120000

Last updated 2025-09-24

No results posted yet for this study

Summary

The Computerized Registry of Patients with Venous Thromboembolism (RIETE) is a multidisciplinary Project initiated in march 2001 and consisting in obtaining an extensive data registry of consecutive patients with venous thromboembolism.

The main objective is to provide information on the Internet to help physicians to improve their knowledge on the natural history of thromboembolic disease, particularly in those subgroups of patients who are usually not recruited in randomized clinical trials (pregnant women, elderly patients, disseminated cancer, severe renal insufficiency, patients with contraindications to anticoagulation therapy, extreme body weight, etc), with the purpose of decreasing mortality, frequency of thromboembolic recurrences as well as bleeding complications and arterial events.

As an additional objective RIETE is also aimed to create predictive scores that help physicians to better identify patients with high risk of presenting some of these complications.

The primary parameters recorded by the registry comprise details of each patient's clinical status, including any coexisting or underlying conditions, and the type, dose, duration and outcome (during the first 3 months of therapy) of antithrombotic treatment. Study endpoints are clinically recognized (and objectively confirmed) recurrences of VTE, major and minor bleeding complications, and death.

Conditions

  • Venous Thromboembolism

Sponsors & Collaborators

  • Manuel Monreal

    lead OTHER

Principal Investigators

  • Manuel Monreal · Foundation for the study of VTE diseases. (FUENTE)

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-03-31
Primary Completion
2026-12-31
Completion
2027-12-31

Countries

  • United States
  • Argentina
  • Austria
  • Belgium
  • Brazil
  • China
  • Colombia
  • Czechia
  • Ecuador
  • Egypt
  • France
  • Germany
  • Greece
  • Honduras
  • Iran
  • Ireland
  • Israel
  • Italy
  • Japan
  • Latvia
  • Mexico
  • Morocco
  • North Macedonia
  • Portugal
  • Spain
  • Switzerland
  • United Kingdom
  • Vietnam

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02832245 on ClinicalTrials.gov